nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—TCN1—gastric juice—pancreatic cancer	0.105	0.468	CbGeAlD
Hydroxocobalamin—TCN1—gall bladder—pancreatic cancer	0.0162	0.0725	CbGeAlD
Hydroxocobalamin—MUT—gall bladder—pancreatic cancer	0.0115	0.0512	CbGeAlD
Hydroxocobalamin—TCN1—islet of Langerhans—pancreatic cancer	0.0106	0.0475	CbGeAlD
Hydroxocobalamin—CASP9—islet of Langerhans—pancreatic cancer	0.0098	0.0437	CbGeAlD
Hydroxocobalamin—AMN—digestive system—pancreatic cancer	0.00843	0.0376	CbGeAlD
Hydroxocobalamin—MUT—islet of Langerhans—pancreatic cancer	0.00752	0.0336	CbGeAlD
Hydroxocobalamin—TCN1—pancreas—pancreatic cancer	0.00748	0.0334	CbGeAlD
Hydroxocobalamin—CUBN—digestive system—pancreatic cancer	0.0071	0.0317	CbGeAlD
Hydroxocobalamin—CASP9—pancreas—pancreatic cancer	0.00689	0.0307	CbGeAlD
Hydroxocobalamin—TCN1—digestive system—pancreatic cancer	0.00639	0.0285	CbGeAlD
Hydroxocobalamin—TCN2—digestive system—pancreatic cancer	0.00574	0.0256	CbGeAlD
Hydroxocobalamin—MUT—pancreas—pancreatic cancer	0.00529	0.0236	CbGeAlD
Hydroxocobalamin—MUT—digestive system—pancreatic cancer	0.00451	0.0202	CbGeAlD
Hydroxocobalamin—MTR—pancreas—pancreatic cancer	0.00414	0.0185	CbGeAlD
Hydroxocobalamin—MTRR—digestive system—pancreatic cancer	0.00406	0.0181	CbGeAlD
Hydroxocobalamin—MTR—digestive system—pancreatic cancer	0.00354	0.0158	CbGeAlD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000808	0.00245	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Irinotecan—pancreatic cancer	0.000808	0.00245	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Erlotinib—pancreatic cancer	0.000804	0.00243	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Tamoxifen—pancreatic cancer	0.000802	0.00243	CcSEcCtD
Hydroxocobalamin—Angiopathy—Gemcitabine—pancreatic cancer	0.000799	0.00242	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Gemcitabine—pancreatic cancer	0.000796	0.00241	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000794	0.0024	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Erlotinib—pancreatic cancer	0.000793	0.0024	CcSEcCtD
Hydroxocobalamin—Chills—Gemcitabine—pancreatic cancer	0.000791	0.00239	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Gemcitabine—pancreatic cancer	0.000787	0.00238	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000786	0.00238	CcSEcCtD
Hydroxocobalamin—Dysphagia—Docetaxel—pancreatic cancer	0.000781	0.00237	CcSEcCtD
Hydroxocobalamin—Oedema—Sunitinib—pancreatic cancer	0.00078	0.00236	CcSEcCtD
Hydroxocobalamin—Pain—Tamoxifen—pancreatic cancer	0.000779	0.00236	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000778	0.00236	CcSEcCtD
Hydroxocobalamin—Infection—Sunitinib—pancreatic cancer	0.000775	0.00235	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Fluorouracil—pancreatic cancer	0.000774	0.00234	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Doxorubicin—pancreatic cancer	0.000773	0.00234	CcSEcCtD
Hydroxocobalamin—Pain—Erlotinib—pancreatic cancer	0.000771	0.00233	CcSEcCtD
Hydroxocobalamin—Erythema—Gemcitabine—pancreatic cancer	0.000767	0.00232	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Sunitinib—pancreatic cancer	0.000765	0.00232	CcSEcCtD
Hydroxocobalamin—Skin disorder—Sunitinib—pancreatic cancer	0.000758	0.00229	CcSEcCtD
Hydroxocobalamin—Erythema—Fluorouracil—pancreatic cancer	0.000754	0.00228	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Epirubicin—pancreatic cancer	0.000748	0.00226	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000731	0.00221	CcSEcCtD
Hydroxocobalamin—Urticaria—Tamoxifen—pancreatic cancer	0.000724	0.00219	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Erlotinib—pancreatic cancer	0.000712	0.00216	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000712	0.00216	CcSEcCtD
Hydroxocobalamin—Malaise—Irinotecan—pancreatic cancer	0.00071	0.00215	CcSEcCtD
Hydroxocobalamin—Phlebitis—Epirubicin—pancreatic cancer	0.000708	0.00214	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Sunitinib—pancreatic cancer	0.000696	0.00211	CcSEcCtD
Hydroxocobalamin—Malaise—Gemcitabine—pancreatic cancer	0.000692	0.00209	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000692	0.00209	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Sunitinib—pancreatic cancer	0.000687	0.00208	CcSEcCtD
Hydroxocobalamin—Eczema—Epirubicin—pancreatic cancer	0.000678	0.00205	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000674	0.00204	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000672	0.00204	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000671	0.00203	CcSEcCtD
Hydroxocobalamin—Pain—Sunitinib—pancreatic cancer	0.000667	0.00202	CcSEcCtD
Hydroxocobalamin—Discomfort—Irinotecan—pancreatic cancer	0.000662	0.00201	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—pancreatic cancer	0.000655	0.00198	CcSEcCtD
Hydroxocobalamin—Chest pain—Gemcitabine—pancreatic cancer	0.000653	0.00198	CcSEcCtD
Hydroxocobalamin—Hot flush—Epirubicin—pancreatic cancer	0.000652	0.00197	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000649	0.00196	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Epirubicin—pancreatic cancer	0.000646	0.00196	CcSEcCtD
Hydroxocobalamin—Discomfort—Gemcitabine—pancreatic cancer	0.000645	0.00195	CcSEcCtD
Hydroxocobalamin—Pruritus—Tamoxifen—pancreatic cancer	0.000644	0.00195	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000643	0.00195	CcSEcCtD
Hydroxocobalamin—Oedema—Irinotecan—pancreatic cancer	0.000643	0.00195	CcSEcCtD
Hydroxocobalamin—Chest pain—Fluorouracil—pancreatic cancer	0.000642	0.00194	CcSEcCtD
Hydroxocobalamin—Infection—Irinotecan—pancreatic cancer	0.000638	0.00193	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000638	0.00193	CcSEcCtD
Hydroxocobalamin—Pruritus—Erlotinib—pancreatic cancer	0.000638	0.00193	CcSEcCtD
Hydroxocobalamin—Discomfort—Fluorouracil—pancreatic cancer	0.000634	0.00192	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Irinotecan—pancreatic cancer	0.00063	0.00191	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—pancreatic cancer	0.000628	0.0019	CcSEcCtD
Hydroxocobalamin—Oedema—Gemcitabine—pancreatic cancer	0.000626	0.0019	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000626	0.0019	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000623	0.00189	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000622	0.00188	CcSEcCtD
Hydroxocobalamin—Infection—Gemcitabine—pancreatic cancer	0.000622	0.00188	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000618	0.00187	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Sunitinib—pancreatic cancer	0.000617	0.00187	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Erlotinib—pancreatic cancer	0.000617	0.00187	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Docetaxel—pancreatic cancer	0.000616	0.00187	CcSEcCtD
Hydroxocobalamin—Oedema—Fluorouracil—pancreatic cancer	0.000616	0.00186	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000616	0.00186	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000614	0.00186	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Docetaxel—pancreatic cancer	0.000613	0.00186	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—pancreatic cancer	0.000612	0.00185	CcSEcCtD
Hydroxocobalamin—Infection—Fluorouracil—pancreatic cancer	0.000612	0.00185	CcSEcCtD
Hydroxocobalamin—Skin disorder—Gemcitabine—pancreatic cancer	0.000608	0.00184	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000604	0.00183	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—pancreatic cancer	0.000603	0.00183	CcSEcCtD
Hydroxocobalamin—Dizziness—Tamoxifen—pancreatic cancer	0.000602	0.00182	CcSEcCtD
Hydroxocobalamin—Tachycardia—Fluorouracil—pancreatic cancer	0.000601	0.00182	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000598	0.00181	CcSEcCtD
Hydroxocobalamin—Dizziness—Erlotinib—pancreatic cancer	0.000596	0.0018	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00059	0.00179	CcSEcCtD
Hydroxocobalamin—Eye disorder—Docetaxel—pancreatic cancer	0.000584	0.00177	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Docetaxel—pancreatic cancer	0.00058	0.00176	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—pancreatic cancer	0.00058	0.00176	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000575	0.00174	CcSEcCtD
Hydroxocobalamin—Rash—Tamoxifen—pancreatic cancer	0.000574	0.00174	CcSEcCtD
Hydroxocobalamin—Dermatitis—Tamoxifen—pancreatic cancer	0.000574	0.00174	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Irinotecan—pancreatic cancer	0.000573	0.00174	CcSEcCtD
Hydroxocobalamin—Headache—Tamoxifen—pancreatic cancer	0.000571	0.00173	CcSEcCtD
Hydroxocobalamin—Rash—Erlotinib—pancreatic cancer	0.000568	0.00172	CcSEcCtD
Hydroxocobalamin—Dermatitis—Erlotinib—pancreatic cancer	0.000568	0.00172	CcSEcCtD
Hydroxocobalamin—Angiopathy—Docetaxel—pancreatic cancer	0.000567	0.00172	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000566	0.00172	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Irinotecan—pancreatic cancer	0.000566	0.00171	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Docetaxel—pancreatic cancer	0.000565	0.00171	CcSEcCtD
Hydroxocobalamin—Headache—Erlotinib—pancreatic cancer	0.000565	0.00171	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000564	0.00171	CcSEcCtD
Hydroxocobalamin—Chills—Docetaxel—pancreatic cancer	0.000561	0.0017	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Docetaxel—pancreatic cancer	0.000559	0.00169	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000558	0.00169	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—pancreatic cancer	0.000555	0.00168	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000555	0.00168	CcSEcCtD
Hydroxocobalamin—Pruritus—Sunitinib—pancreatic cancer	0.000552	0.00167	CcSEcCtD
Hydroxocobalamin—Pain—Irinotecan—pancreatic cancer	0.00055	0.00166	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000549	0.00166	CcSEcCtD
Hydroxocobalamin—Mental disorder—Docetaxel—pancreatic cancer	0.000548	0.00166	CcSEcCtD
Hydroxocobalamin—Erythema—Docetaxel—pancreatic cancer	0.000544	0.00165	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000542	0.00164	CcSEcCtD
Hydroxocobalamin—Nausea—Tamoxifen—pancreatic cancer	0.000541	0.00164	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00054	0.00164	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000536	0.00162	CcSEcCtD
Hydroxocobalamin—Pain—Gemcitabine—pancreatic cancer	0.000535	0.00162	CcSEcCtD
Hydroxocobalamin—Nausea—Erlotinib—pancreatic cancer	0.000535	0.00162	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Sunitinib—pancreatic cancer	0.000534	0.00162	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000531	0.00161	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Irinotecan—pancreatic cancer	0.00053	0.0016	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—pancreatic cancer	0.000527	0.0016	CcSEcCtD
Hydroxocobalamin—Pain—Fluorouracil—pancreatic cancer	0.000526	0.00159	CcSEcCtD
Hydroxocobalamin—Dizziness—Sunitinib—pancreatic cancer	0.000516	0.00156	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000516	0.00156	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000513	0.00155	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Irinotecan—pancreatic cancer	0.000508	0.00154	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000507	0.00154	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000495	0.0015	CcSEcCtD
Hydroxocobalamin—Rash—Sunitinib—pancreatic cancer	0.000492	0.00149	CcSEcCtD
Hydroxocobalamin—Dermatitis—Sunitinib—pancreatic cancer	0.000491	0.00149	CcSEcCtD
Hydroxocobalamin—Urticaria—Fluorouracil—pancreatic cancer	0.000489	0.00148	CcSEcCtD
Hydroxocobalamin—Headache—Sunitinib—pancreatic cancer	0.000489	0.00148	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—pancreatic cancer	0.000488	0.00148	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000487	0.00147	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000473	0.00143	CcSEcCtD
Hydroxocobalamin—Chest pain—Docetaxel—pancreatic cancer	0.000463	0.0014	CcSEcCtD
Hydroxocobalamin—Nausea—Sunitinib—pancreatic cancer	0.000463	0.0014	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00046	0.00139	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000453	0.00137	CcSEcCtD
Hydroxocobalamin—Oedema—Docetaxel—pancreatic cancer	0.000444	0.00135	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000444	0.00135	CcSEcCtD
Hydroxocobalamin—Pruritus—Gemcitabine—pancreatic cancer	0.000443	0.00134	CcSEcCtD
Hydroxocobalamin—Infection—Docetaxel—pancreatic cancer	0.000441	0.00134	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Irinotecan—pancreatic cancer	0.00044	0.00133	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000436	0.00132	CcSEcCtD
Hydroxocobalamin—Pruritus—Fluorouracil—pancreatic cancer	0.000435	0.00132	CcSEcCtD
Hydroxocobalamin—Tachycardia—Docetaxel—pancreatic cancer	0.000434	0.00131	CcSEcCtD
Hydroxocobalamin—Skin disorder—Docetaxel—pancreatic cancer	0.000432	0.00131	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000428	0.0013	CcSEcCtD
Hydroxocobalamin—Dizziness—Irinotecan—pancreatic cancer	0.000425	0.00129	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000421	0.00128	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000417	0.00126	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000415	0.00126	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—pancreatic cancer	0.000413	0.00125	CcSEcCtD
Hydroxocobalamin—Dizziness—Fluorouracil—pancreatic cancer	0.000407	0.00123	CcSEcCtD
Hydroxocobalamin—Rash—Irinotecan—pancreatic cancer	0.000405	0.00123	CcSEcCtD
Hydroxocobalamin—Dermatitis—Irinotecan—pancreatic cancer	0.000405	0.00123	CcSEcCtD
Hydroxocobalamin—Headache—Irinotecan—pancreatic cancer	0.000403	0.00122	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Docetaxel—pancreatic cancer	0.000396	0.0012	CcSEcCtD
Hydroxocobalamin—Rash—Gemcitabine—pancreatic cancer	0.000395	0.0012	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gemcitabine—pancreatic cancer	0.000394	0.00119	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—pancreatic cancer	0.000394	0.00119	CcSEcCtD
Hydroxocobalamin—Headache—Gemcitabine—pancreatic cancer	0.000392	0.00119	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000391	0.00119	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Docetaxel—pancreatic cancer	0.000391	0.00118	CcSEcCtD
Hydroxocobalamin—Rash—Fluorouracil—pancreatic cancer	0.000388	0.00118	CcSEcCtD
Hydroxocobalamin—Dermatitis—Fluorouracil—pancreatic cancer	0.000388	0.00117	CcSEcCtD
Hydroxocobalamin—Headache—Fluorouracil—pancreatic cancer	0.000386	0.00117	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000385	0.00117	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000384	0.00116	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000384	0.00116	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—pancreatic cancer	0.000383	0.00116	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000383	0.00116	CcSEcCtD
Hydroxocobalamin—Nausea—Irinotecan—pancreatic cancer	0.000382	0.00116	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—pancreatic cancer	0.000381	0.00115	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00038	0.00115	CcSEcCtD
Hydroxocobalamin—Pain—Docetaxel—pancreatic cancer	0.00038	0.00115	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—pancreatic cancer	0.000378	0.00115	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—pancreatic cancer	0.000377	0.00114	CcSEcCtD
Hydroxocobalamin—Nausea—Gemcitabine—pancreatic cancer	0.000372	0.00113	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—pancreatic cancer	0.00037	0.00112	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—pancreatic cancer	0.000367	0.00111	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000366	0.00111	CcSEcCtD
Hydroxocobalamin—Nausea—Fluorouracil—pancreatic cancer	0.000366	0.00111	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—pancreatic cancer	0.000365	0.0011	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000362	0.0011	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—pancreatic cancer	0.000354	0.00107	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000353	0.00107	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000352	0.00107	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Docetaxel—pancreatic cancer	0.000351	0.00106	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—pancreatic cancer	0.00035	0.00106	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000349	0.00106	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—pancreatic cancer	0.000342	0.00104	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000341	0.00103	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—pancreatic cancer	0.00034	0.00103	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—pancreatic cancer	0.000337	0.00102	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—pancreatic cancer	0.000331	0.001	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000327	0.000991	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000315	0.000955	CcSEcCtD
Hydroxocobalamin—Pruritus—Docetaxel—pancreatic cancer	0.000314	0.000952	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—pancreatic cancer	0.000313	0.000947	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—pancreatic cancer	0.000312	0.000945	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00031	0.00094	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—pancreatic cancer	0.000309	0.000935	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—pancreatic cancer	0.000306	0.000928	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Docetaxel—pancreatic cancer	0.000304	0.00092	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—pancreatic cancer	0.0003	0.000907	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.0003	0.000907	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—pancreatic cancer	0.000298	0.000901	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000294	0.00089	CcSEcCtD
Hydroxocobalamin—Dizziness—Docetaxel—pancreatic cancer	0.000294	0.00089	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—pancreatic cancer	0.000292	0.000886	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—pancreatic cancer	0.000291	0.000881	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—pancreatic cancer	0.000289	0.000876	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000287	0.00087	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—pancreatic cancer	0.000286	0.000865	CcSEcCtD
Hydroxocobalamin—Rash—Docetaxel—pancreatic cancer	0.00028	0.000848	CcSEcCtD
Hydroxocobalamin—Dermatitis—Docetaxel—pancreatic cancer	0.00028	0.000847	CcSEcCtD
Hydroxocobalamin—Headache—Docetaxel—pancreatic cancer	0.000278	0.000843	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000277	0.00084	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—pancreatic cancer	0.000277	0.00084	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—pancreatic cancer	0.000275	0.000834	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000272	0.000823	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—pancreatic cancer	0.000271	0.000819	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—pancreatic cancer	0.000269	0.000816	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—pancreatic cancer	0.000267	0.000809	CcSEcCtD
Hydroxocobalamin—Nausea—Docetaxel—pancreatic cancer	0.000264	0.000799	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—pancreatic cancer	0.000264	0.000799	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000259	0.000783	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—pancreatic cancer	0.000256	0.000776	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000247	0.000749	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000247	0.000748	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000244	0.000739	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000239	0.000725	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—pancreatic cancer	0.000238	0.000721	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—pancreatic cancer	0.000237	0.000718	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—pancreatic cancer	0.000237	0.000717	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000228	0.000692	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000221	0.000669	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—pancreatic cancer	0.00022	0.000667	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000219	0.000664	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—pancreatic cancer	0.000212	0.000642	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—pancreatic cancer	0.000205	0.000621	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000204	0.000619	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—pancreatic cancer	0.000198	0.0006	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—pancreatic cancer	0.000196	0.000594	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—pancreatic cancer	0.00019	0.000574	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—pancreatic cancer	0.000189	0.000572	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—pancreatic cancer	0.000189	0.000572	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—pancreatic cancer	0.000188	0.000568	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—pancreatic cancer	0.000183	0.000555	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—pancreatic cancer	0.000178	0.000539	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—pancreatic cancer	0.000175	0.000529	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—pancreatic cancer	0.000175	0.000529	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—pancreatic cancer	0.000174	0.000526	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—pancreatic cancer	0.000165	0.000499	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—NRAS—pancreatic cancer	6.55e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TGFB1—pancreatic cancer	6.55e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFB1—pancreatic cancer	6.55e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTEN—pancreatic cancer	6.54e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTEN—pancreatic cancer	6.54e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOE—pancreatic cancer	6.46e-05	0.000145	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—pancreatic cancer	6.42e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—pancreatic cancer	6.42e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CD—pancreatic cancer	6.41e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CTNNB1—pancreatic cancer	6.41e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTHLH—pancreatic cancer	6.35e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTCH1—pancreatic cancer	6.35e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CB—pancreatic cancer	6.34e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CB—pancreatic cancer	6.34e-05	0.000142	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—pancreatic cancer	6.29e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—pancreatic cancer	6.29e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CD—pancreatic cancer	6.28e-05	0.000141	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CB—pancreatic cancer	6.25e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTEN—pancreatic cancer	6.24e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—pancreatic cancer	6.18e-05	0.000139	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTEN—pancreatic cancer	6.15e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—pancreatic cancer	6.1e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—pancreatic cancer	6.09e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TGFB1—pancreatic cancer	6.09e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SMAD4—pancreatic cancer	6.08e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SRC—pancreatic cancer	6.07e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—SRC—pancreatic cancer	6.07e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—pancreatic cancer	6.07e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—pancreatic cancer	6.07e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CB—pancreatic cancer	6.05e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CB—pancreatic cancer	6e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—pancreatic cancer	6e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CG—pancreatic cancer	5.98e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—pancreatic cancer	5.97e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOTCH1—pancreatic cancer	5.96e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HES1—pancreatic cancer	5.94e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—pancreatic cancer	5.91e-05	0.000133	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—pancreatic cancer	5.85e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—pancreatic cancer	5.85e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—pancreatic cancer	5.84e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—pancreatic cancer	5.84e-05	0.000131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SST—pancreatic cancer	5.81e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SRC—pancreatic cancer	5.79e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—pancreatic cancer	5.78e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTEN—pancreatic cancer	5.76e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGF—pancreatic cancer	5.76e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JAG1—pancreatic cancer	5.68e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH3—pancreatic cancer	5.66e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—pancreatic cancer	5.64e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—pancreatic cancer	5.64e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CB—pancreatic cancer	5.58e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—pancreatic cancer	5.58e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—pancreatic cancer	5.57e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—pancreatic cancer	5.57e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—pancreatic cancer	5.57e-05	0.000125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—pancreatic cancer	5.54e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—pancreatic cancer	5.53e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTEN—pancreatic cancer	5.48e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTEN—pancreatic cancer	5.48e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CB—pancreatic cancer	5.48e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—pancreatic cancer	5.46e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—pancreatic cancer	5.44e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—pancreatic cancer	5.44e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFB1—pancreatic cancer	5.43e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFB1—pancreatic cancer	5.43e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—pancreatic cancer	5.43e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2L1—pancreatic cancer	5.41e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOE—pancreatic cancer	5.41e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PTEN—pancreatic cancer	5.4e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TSC2—pancreatic cancer	5.38e-05	0.000121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CNR1—pancreatic cancer	5.36e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SRC—pancreatic cancer	5.34e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—pancreatic cancer	5.32e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—pancreatic cancer	5.32e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CD—pancreatic cancer	5.26e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—pancreatic cancer	5.23e-05	0.000117	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—pancreatic cancer	5.21e-05	0.000117	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—pancreatic cancer	5.19e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—pancreatic cancer	5.19e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—pancreatic cancer	5.18e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—pancreatic cancer	5.18e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GCG—pancreatic cancer	5.17e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—pancreatic cancer	5.16e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—pancreatic cancer	5.16e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—pancreatic cancer	5.15e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—pancreatic cancer	5.14e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CD—pancreatic cancer	5.12e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—pancreatic cancer	5.1e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—pancreatic cancer	5.08e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—pancreatic cancer	5.03e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—pancreatic cancer	5.03e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SRC—pancreatic cancer	5.01e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—pancreatic cancer	4.98e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—pancreatic cancer	4.98e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TSC2—pancreatic cancer	4.97e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGTR1—pancreatic cancer	4.94e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKBIA—pancreatic cancer	4.91e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—pancreatic cancer	4.88e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STK11—pancreatic cancer	4.86e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOE—pancreatic cancer	4.86e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—pancreatic cancer	4.85e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—pancreatic cancer	4.83e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—pancreatic cancer	4.82e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—pancreatic cancer	4.81e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—pancreatic cancer	4.79e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—pancreatic cancer	4.79e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—pancreatic cancer	4.79e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—pancreatic cancer	4.78e-05	0.000107	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—pancreatic cancer	4.73e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—pancreatic cancer	4.71e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGF—pancreatic cancer	4.7e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—pancreatic cancer	4.68e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—pancreatic cancer	4.67e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—pancreatic cancer	4.67e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—pancreatic cancer	4.63e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—pancreatic cancer	4.62e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—pancreatic cancer	4.62e-05	0.000104	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—pancreatic cancer	4.59e-05	0.000103	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—pancreatic cancer	4.55e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—pancreatic cancer	4.55e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—pancreatic cancer	4.54e-05	0.000102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—pancreatic cancer	4.49e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—pancreatic cancer	4.46e-05	0.0001	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—pancreatic cancer	4.42e-05	9.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—pancreatic cancer	4.42e-05	9.92e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—pancreatic cancer	4.4e-05	9.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—pancreatic cancer	4.39e-05	9.85e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—pancreatic cancer	4.39e-05	9.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—pancreatic cancer	4.37e-05	9.81e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—pancreatic cancer	4.34e-05	9.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGF—pancreatic cancer	4.34e-05	9.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—pancreatic cancer	4.29e-05	9.62e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—pancreatic cancer	4.27e-05	9.58e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—pancreatic cancer	4.27e-05	9.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMAD4—pancreatic cancer	4.26e-05	9.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—pancreatic cancer	4.23e-05	9.49e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—pancreatic cancer	4.23e-05	9.49e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—pancreatic cancer	4.22e-05	9.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—pancreatic cancer	4.22e-05	9.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—pancreatic cancer	4.18e-05	9.37e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—pancreatic cancer	4.17e-05	9.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HES1—pancreatic cancer	4.16e-05	9.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—pancreatic cancer	4.15e-05	9.3e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—pancreatic cancer	4.08e-05	9.14e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—pancreatic cancer	4.06e-05	9.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—pancreatic cancer	3.98e-05	8.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—pancreatic cancer	3.96e-05	8.89e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—pancreatic cancer	3.96e-05	8.88e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—pancreatic cancer	3.93e-05	8.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—pancreatic cancer	3.92e-05	8.8e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—pancreatic cancer	3.87e-05	8.67e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—pancreatic cancer	3.87e-05	8.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—pancreatic cancer	3.86e-05	8.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—pancreatic cancer	3.86e-05	8.65e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—pancreatic cancer	3.85e-05	8.63e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—pancreatic cancer	3.81e-05	8.55e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—pancreatic cancer	3.81e-05	8.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—pancreatic cancer	3.81e-05	8.55e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—pancreatic cancer	3.77e-05	8.46e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—pancreatic cancer	3.77e-05	8.46e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—pancreatic cancer	3.76e-05	8.44e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—pancreatic cancer	3.74e-05	8.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—pancreatic cancer	3.7e-05	8.31e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—pancreatic cancer	3.69e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—pancreatic cancer	3.66e-05	8.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—pancreatic cancer	3.65e-05	8.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—pancreatic cancer	3.64e-05	8.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—pancreatic cancer	3.63e-05	8.15e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—pancreatic cancer	3.6e-05	8.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—pancreatic cancer	3.58e-05	8.02e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—pancreatic cancer	3.54e-05	7.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—pancreatic cancer	3.52e-05	7.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—pancreatic cancer	3.49e-05	7.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TSC2—pancreatic cancer	3.48e-05	7.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—pancreatic cancer	3.45e-05	7.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—pancreatic cancer	3.44e-05	7.72e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—pancreatic cancer	3.4e-05	7.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOE—pancreatic cancer	3.4e-05	7.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—pancreatic cancer	3.38e-05	7.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—pancreatic cancer	3.36e-05	7.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—pancreatic cancer	3.34e-05	7.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—pancreatic cancer	3.33e-05	7.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—pancreatic cancer	3.33e-05	7.47e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—pancreatic cancer	3.32e-05	7.45e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—pancreatic cancer	3.23e-05	7.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—pancreatic cancer	3.23e-05	7.24e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—pancreatic cancer	3.21e-05	7.19e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—pancreatic cancer	3.2e-05	7.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKBIA—pancreatic cancer	3.17e-05	7.11e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—pancreatic cancer	3.16e-05	7.09e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—pancreatic cancer	3.16e-05	7.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—pancreatic cancer	3.15e-05	7.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—pancreatic cancer	3.14e-05	7.05e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—pancreatic cancer	3.14e-05	7.03e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—pancreatic cancer	3.11e-05	6.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—pancreatic cancer	3.09e-05	6.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—pancreatic cancer	3.07e-05	6.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGF—pancreatic cancer	3.04e-05	6.81e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—pancreatic cancer	3.01e-05	6.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—pancreatic cancer	2.99e-05	6.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—pancreatic cancer	2.98e-05	6.68e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—pancreatic cancer	2.96e-05	6.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—pancreatic cancer	2.92e-05	6.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—pancreatic cancer	2.9e-05	6.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—pancreatic cancer	2.81e-05	6.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—pancreatic cancer	2.81e-05	6.3e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—pancreatic cancer	2.8e-05	6.27e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—pancreatic cancer	2.78e-05	6.24e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—pancreatic cancer	2.73e-05	6.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—pancreatic cancer	2.72e-05	6.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—pancreatic cancer	2.7e-05	6.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—pancreatic cancer	2.69e-05	6.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—pancreatic cancer	2.6e-05	5.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—pancreatic cancer	2.59e-05	5.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—pancreatic cancer	2.56e-05	5.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—pancreatic cancer	2.52e-05	5.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—pancreatic cancer	2.42e-05	5.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—pancreatic cancer	2.41e-05	5.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—pancreatic cancer	2.41e-05	5.4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—pancreatic cancer	2.36e-05	5.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—pancreatic cancer	2.35e-05	5.28e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—pancreatic cancer	2.28e-05	5.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—pancreatic cancer	2.28e-05	5.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—pancreatic cancer	2.26e-05	5.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—pancreatic cancer	2.23e-05	5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—pancreatic cancer	2.22e-05	4.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—pancreatic cancer	2.22e-05	4.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—pancreatic cancer	2.16e-05	4.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—pancreatic cancer	2.11e-05	4.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—pancreatic cancer	2.09e-05	4.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—pancreatic cancer	2.05e-05	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—pancreatic cancer	2.05e-05	4.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—pancreatic cancer	2.05e-05	4.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—pancreatic cancer	2.03e-05	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—pancreatic cancer	1.9e-05	4.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—pancreatic cancer	1.89e-05	4.23e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—pancreatic cancer	1.86e-05	4.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—pancreatic cancer	1.84e-05	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—pancreatic cancer	1.82e-05	4.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—pancreatic cancer	1.81e-05	4.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—pancreatic cancer	1.81e-05	4.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—pancreatic cancer	1.69e-05	3.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—pancreatic cancer	1.69e-05	3.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—pancreatic cancer	1.67e-05	3.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—pancreatic cancer	1.65e-05	3.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—pancreatic cancer	1.56e-05	3.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—pancreatic cancer	1.43e-05	3.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—pancreatic cancer	1.39e-05	3.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—pancreatic cancer	1.33e-05	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—pancreatic cancer	1.17e-05	2.63e-05	CbGpPWpGaD
